tradingkey.logo

Novo Nordisk to engage with US over drug prices, Ritzau news agency reports

ReutersMay 12, 2025 3:51 PM

- Weight-loss and diabetes drug maker Novo Nordisk NOVOb.CO will engage with the U.S. government over U.S. policy proposals to bring down prices, the Danish company said in a statement to news agency Ritzau on Monday.

"We agree that Americans need access to medicines at better prices, and we will continue to engage with policymakers to develop and implement more effective solutions," Ritzau quoted Novo Nordisk as saying.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI